刘翩,王斌,吴国明.吉非替尼维持治疗晚期肺腺癌长期生存1例[J].第三军医大学学报,2012,34(15):1491. [2]刘瑞青,申淑景,马杰,等.肺腺癌组织中TTF-1和SPA的表达对EGFR突变的临床预测价值[J].第三军医大学学报,2012,34(22):2314. Liu Ruiqing,Shen Shujing,Ma Jie,et al.Clinical value of TTF-1 and SPA expression in predicting EGFR mutations in lung adenocarcinoma[J].J Third Mil Med Univ,2012,34(18):2314. [3]刘小军,张雪琳,李莎莎,等.172例肺腺癌脑转移影响因素的临床分析[J].第三军医大学学报,2013,35(01):73. Liu Xiaojun,Zhang Xuelin,Li Shasha,et al.Clinical analysis of influencing factors for 172 lung adenocarcinoma patients with brain metastasis[J].J Third Mil Med Univ,2013,35(18):73. [4]余祖滨,白莉,姚珂,等.SOCS3对肺腺癌细胞株A549迁移和侵袭能力的影响[J].第三军医大学学报,2008,30(07):588. YU Zu-bin,BAI Li,YAO Ke,et al.Effects of SOCS3 gene on migration and invasion of lung adenocarcinoma cell line A549[J].J Third Mil Med Univ,2008,30(18):588. [5]庞华,罗弋,李少林.人源肺腺癌噬菌体抗体库的构建及初步筛选[J].第三军医大学学报,2008,30(22):2082. PANG Hua,LUO Yi,LI Shao-lin.Construction of and screening for phage antibody library of human lung adenocarcinoma[J].J Third Mil Med Univ,2008,30(18):2082. [6]白莉,祝蓉,陈智鸿,等.靶向EGFR基因的siRNA表达载体构建及其生物学效应的研究[J].第三军医大学学报,2005,27(23):2307. [7]熊玮,钱桂生,黄桂君.氯氨顺铂诱导耐药后肺腺癌细胞株生物学特性及染色体核型分析[J].第三军医大学学报,2005,27(22):2226. [8]郭芮伶,吴国明,戢福云,等.多西紫杉醇对肺腺癌多药耐药细胞A549/CDDP及其亲代细胞作用机制的初步研究[J].第三军医大学学报,2005,27(07):610. [9]张雪淋,原薇薇,傅华,等.HOXA10在肺腺癌中的过表达及其临床意义[J].第三军医大学学报,2013,35(05):468. Zhang Xuelin,Yuan Weiwei,Fu Hua,et al.Over-expression and clinical significance of HOXA10 in human lung adenocarcinoma[J].J Third Mil Med Univ,2013,35(18):468. [10]王洁,李建国,庞华,等.抗HIF-1α肺腺癌人源单链抗体的制备和放射免疫显像[J].第三军医大学学报,2010,32(17):1851. Wang Jie,Li Jianguo,Pang Hua,et al.Preparation of human anti-HIF-1α scFv of lung adenocarcinoma and its radioimmunoimaging[J].J Third Mil Med Univ,2010,32(18):1851.
